Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women?s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men?s and women?s health, and prostate health. The company?s products also inc
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-1.55%||Sales Growth - 4 Quarters||-15.23%||Sales Growth - Q/Q||-10.73%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-2.55%||ROE||-8.7%||ROI||-3.62%|
|Current Ratio||1.55||Quick Ratio||1.37||Long Term Debt/Equity||2.86||Debt Ratio||0.83|
|Gross Margin||49.62%||Operating Margin||-27.98%||Net Profit Margin||-11.54%||Dividend Payout Ratio|
|Cash From Financing Activities||Cash From Investing Activities||996.86 M||Cash From Operating Activities||-930.48 M||Gross Profit||329.86 M|
|Net Profit||-89.81 M||Operating Profit||45.75 M||Total Assets||14.15 B||Total Current Assets||5.33 B|
|Total Current Liabilities||3.44 B||Total Debt||5.39 B||Total Liabilities||10.01 B||Total Revenue||714.13 M|
|High 52 week||18.3||Low 52 week||5.62||Last close||6.52||Last change||-1.21%|
|RSI||32.56||Average true range||0.51||Beta||0.74||Volume||2.59 M|
|Simple moving average 20 days||-12.43%||Simple moving average 50 days||-17.18%||Simple moving average 200 days||-44.67%|
|Performance Week||-19.11%||Performance Month||-8.81%||Performance Quart||-38.32%||Performance Half||-51.78%|
|Performance Year||4.32%||Performance Year-to-date||-10.68%||Volatility daily||5.27%||Volatility weekly||11.79%|
|Volatility monthly||24.16%||Volatility yearly||83.68%||Relative Volume||179.67%||Average Volume||3.55 M|
|New High||New Low|
2019-09-16 15:14:19 | OxyContin maker Purdue Pharma files for bankruptcy
2019-09-11 16:06:23 | Francis Chou's Chou Europe Fund Semi-Annual 2019 Commentary
2019-09-11 12:13:04 | Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up
2019-09-10 16:21:49 | Francis Chou's Chou Associates Fund Semi-Annual 2019 Letter
2019-09-10 04:56:08 | Endo Files BLA for CCH With the FDA for Cellulite Candidate Revised
2019-09-09 17:28:09 | Mallinckrodt MNK to Resolve Opioid Cases with Ohio Counties
2019-09-09 09:50:01 | Endo International Files BLA for Label Expansion of Xiaflex
2019-09-06 16:31:00 | Why DocuSign, Endo International, and Guidewire Software Jumped Today
2019-09-06 11:55:38 | Opioid Crisis Fallout Earns Short-Sellers an $880 Million Payday
2019-09-06 11:52:57 | Why Endo International Stock Is Soaring Today
2019-09-06 08:08:12 | Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation
2019-09-06 08:00:49 | Opioid Crisis Squeezes Last Air Out of a Stock Bubble
2019-09-05 16:49:45 | Endo agrees to pay $10M to settle Ohio opioid lawsuits
2019-09-05 12:00:00 | Why Endo International Shares Are Tanking Today
2019-09-05 10:35:02 | Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease
2019-09-05 00:36:25 | Edited Transcript of ENDP earnings conference call or presentation 6-Aug-19 11:30am GMT
2019-09-04 09:30:01 | Endo ENDP Up 5.8% Since Last Earnings Report: Can It Continue?
2019-09-04 07:30:00 | Endo Announces Approval of First Generic Orfadin® in U.S.
2019-09-02 09:41:01 | Allergan Settles Ahead of Multi-District Opioid Litigation
2019-08-30 08:00:12 | Will Opioid Litigation Take its Toll on Pharma Companies?
2019-08-28 08:35:38 | Endo International plc NASDAQ:ENDP Insiders Have Been Selling
2019-08-27 11:14:16 | J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read
2019-08-27 11:01:03 | J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case
2019-08-27 10:40:02 | Case-Shiller Index Nudges Up
2019-08-27 07:36:44 | Will Johnson & Johnson Become the Next Teva?
2019-08-23 10:15:02 | J&J's JNJ Opioid Lawsuit Verdict in Oklahoma Due Next Week
2019-08-22 07:42:11 | Mallinckrodt MNK Stock Down 70.8% YTD on Numerous Lawsuits
2019-08-21 16:15:54 | Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms?
2019-08-21 13:38:05 | Endo Up on Settlement of a Few Cases Related to Opioid Drugs
2019-08-21 10:42:02 | Are Options Traders Betting on a Big Move in Endo ENDP Stock?
2019-08-20 16:30:00 | Why Baidu, Endo International, and Hilton Grand Vacations Jumped Today
2019-08-20 12:20:08 | Endo, Allergan could avoid trial with opioid settlements
2019-08-20 11:54:00 | Why Endo International Shares Are Soaring Again Today
2019-08-20 10:20:42 | UPDATE 2-Drugmakers Endo, Allergan agree to $15 mln in settlements in major opioid case
2019-08-20 10:15:11 | Endo, Allergan could avoid trial with Ohio over opioid crisis
2019-08-20 10:12:00 | Endo's stock soars after settlement agreement on track 1 opioid cases
2019-08-20 09:28:00 | Endo Announces Settlement in Principle to Resolve _Track 1_ Opioid Cases
2019-08-20 06:43:00 | Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit
2019-08-20 03:23:00 | [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report
2019-08-19 16:36:00 | Why Mallinckrodt and Endo International Shares Jumped Today
2019-08-13 10:05:02 | Is Endo International ENDP A Great Pick for Value Investors?
2019-08-09 10:17:02 | BioDelivery BDSI Earnings & Sales Beat Estimates in Q2
2019-08-07 11:15:03 | Endo ENDP Q2 Earnings & Revenues Beat Estimates, Down Y/Y
2019-08-06 20:24:29 | Endo International ENDP Q2 2019 Earnings Call Transcript